{"organizations": [], "uuid": "93e2858c3145ffdfc2469c0b4f272a91ab3edaae", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 1, "shares": 1, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180509.html", "section_title": "Archive News &amp; Video for Wednesday, 09 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-array-biopharma-says-entered-into/brief-array-biopharma-says-entered-into-controlled-equity-offerings-sales-agreement-with-cantor-fitzgerald-idUSFWN1SG18Q", "country": "US", "domain_rank": 408, "title": "BRIEF-Array Biopharma Says Entered Into Controlled Equity Offerings Sales Agreement With Cantor Fitzgerald", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-05-09T20:38:00.000+03:00", "replies_count": 0, "uuid": "93e2858c3145ffdfc2469c0b4f272a91ab3edaae"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-array-biopharma-says-entered-into/brief-array-biopharma-says-entered-into-controlled-equity-offerings-sales-agreement-with-cantor-fitzgerald-idUSFWN1SG18Q", "ord_in_thread": 0, "title": "BRIEF-Array Biopharma Says Entered Into Controlled Equity Offerings Sales Agreement With Cantor Fitzgerald", "locations": [], "entities": {"persons": [{"name": "cantor fitzgerald", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "biopharma inc", "sentiment": "negative"}, {"name": "cantor fitzgerald & co", "sentiment": "none"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 9 (Reuters) - Array Biopharma Inc:\n* ARRAY BIOPHARMA INC SAYS ENTERED INTO CONTROLLED EQUITY OFFERINGSM SALES AGREEMENT WITH CANTOR FITZGERALD & CO - SEC FILING\n* ARRAY BIOPHARMA INC SAYS MAY OFFER AND SELL UP TO $125.0 MILLION OF COMMON STOCK OF THROUGH CANTOR FITZGERALD & CO Source text: ( bit.ly/2FY8NeE ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://bit.ly/2FY8NeE", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-09T20:38:00.000+03:00", "crawled": "2018-05-10T17:39:56.009+03:00", "highlightTitle": ""}